BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15536023)

  • 1. Treatment satisfaction after commencement of insulin in Type 2 diabetes.
    Wilson M; Moore MP; Lunt H
    Diabetes Res Clin Pract; 2004 Dec; 66(3):263-7. PubMed ID: 15536023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ.
    Bradley C; Plowright R; Stewart J; Valentine J; Witthaus E
    Health Qual Life Outcomes; 2007 Oct; 5():57. PubMed ID: 17927832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Satisfaction of patients with type 2 diabetes mellitus after starting treatment with insulin].
    Mancera-Romero J; Carramiñana-Barrera F; Muñoz-González L; Guillén-Álvarez P; Murillo-García D; Sánchez-Pérez MR;
    Semergen; 2016; 42(5):298-306. PubMed ID: 26188491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries.
    Boels AM; Vos RC; Hermans TGT; Zuithoff NPA; Müller N; Khunti K; Rutten GEHM;
    BMJ Open; 2017 Jul; 7(7):e016180. PubMed ID: 28701411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well-being and symptoms in relation to insulin therapy in type 2 diabetes.
    de Sonnaville JJ; Snoek FJ; Colly LP; Devillé W; Wijkel D; Heine RJ
    Diabetes Care; 1998 Jun; 21(6):919-24. PubMed ID: 9614608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.
    Cappelleri JC; Cefalu WT; Rosenstock J; Kourides IA; Gerber RA
    Clin Ther; 2002 Apr; 24(4):552-64. PubMed ID: 12017400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus.
    Polonsky W; Traylor L; Wei W; Shi R; Ameer B; Vlajnic A; Nicolucci A
    Diabetes Obes Metab; 2014 Mar; 16(3):255-61. PubMed ID: 24028669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs.
    Peyrot M; Rubin RR; Polonsky WH; Best JH
    Curr Med Res Opin; 2010 May; 26(5):1047-54. PubMed ID: 20199136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and patient satisfaction with U-500 insulin use.
    Dailey AM; Williams S; Taneja D; Tannock LR
    Diabetes Res Clin Pract; 2010 Jun; 88(3):259-64. PubMed ID: 20226557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expectations about insulin therapy, perceived insulin-delivery system social acceptability, and insulin treatment satisfaction contribute to decreases in insulin therapy self-efficacy in patients with type 2 diabetes after 36 weeks insulin therapy.
    Hayes RP; Curtis B; Ilag L; Nelson DR; Wong M; Funnell M
    J Diabetes; 2013 Sep; 5(3):358-67. PubMed ID: 23489710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC).
    Kleefstra N; Hortensius J; Logtenberg SJ; Slingerland RJ; Groenier KH; Houweling ST; Gans RO; van Ballegooie E; Bilo HJ
    Neth J Med; 2010 Aug; 68(1):311-6. PubMed ID: 20739728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes.
    Secnik Boye K; Matza LS; Oglesby A; Malley K; Kim S; Hayes RP; Brodows R
    Health Qual Life Outcomes; 2006 Oct; 4():80. PubMed ID: 17034640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and satisfaction with treatment in subjects with type 2 diabetes: results in Spain of the PANORAMA study.
    Depablos-Velasco P; Salguero-Chaves E; Mata-Poyo J; Derivas-Otero B; García-Sánchez R; Viguera-Ester P
    Endocrinol Nutr; 2014 Jan; 61(1):18-26. PubMed ID: 24055176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a treatment and teaching refresher programme for the optimization of intensified insulin therapy in type 1 diabetes.
    Müller N; Kloos C; Sämann A; Wolf G; Müller UA
    Patient Educ Couns; 2013 Oct; 93(1):108-13. PubMed ID: 23747089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes.
    Farmer AJ; Oke J; Stevens R; Holman RR
    Diabetes Obes Metab; 2011 Dec; 13(12):1136-41. PubMed ID: 21767341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes.
    Ashwell SG; Bradley C; Stephens JW; Witthaus E; Home PD
    Diabetes Care; 2008 Jun; 31(6):1112-7. PubMed ID: 18339977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes: Empowerment Perceptions and Diabetes Distress as Important Determinants.
    Chen SY; Hsu HC; Wang RH; Lee YJ; Hsieh CH
    Biol Res Nurs; 2019 Mar; 21(2):182-189. PubMed ID: 30585081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications.
    Alcubierre N; Rubinat E; Traveset A; Martinez-Alonso M; Hernandez M; Jurjo C; Mauricio D
    Health Qual Life Outcomes; 2014 Aug; 12():131. PubMed ID: 25138117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus.
    Chlup R; Zapletalová J; Seckar P; Malá E; Doubravová B; Táncosová S; Chlupová L; Pukowietz L; Zatloukal P
    Diabetes Technol Ther; 2007 Jun; 9(3):223-31. PubMed ID: 17561792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions and attitudes are primary contributors to insulin delivery system satisfaction in people with type 2 diabetes.
    Hayes RP; Fitzgerald JT
    Diabetes Technol Ther; 2009 Jul; 11(7):419-26. PubMed ID: 19580354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.